Tesamorelin, a synthetic form of growth hormone-releasing hormone (GHRH), is used to reduce excess fat around the stomach caused by certain HIV medications, a condition known as lipodystrophy. It is specifically designed for adults with HIV who have developed increased body fat in the abdominal area due to lipodystrophy.
The medication is not intended for weight loss or to treat obesity, and it should not be used by individuals who are pregnant. It functions by increasing the production of a natural substance that can decrease the amount of body fat. Tesamorelin is administered through subcutaneous injections and is typically used once a day.
Before starting tesamorelin treatment, it is crucial to inform the healthcare provider about any known allergies, existing medical conditions (such as heart disease, high blood pressure, kidney disease, diabetes, or cancer), and ongoing medications. Regular monitoring and follow-up appointments with a doctor are essential to evaluate the body's response to tesamorelin treatment.
The medication should be prepared and used according to specific instructions provided by the healthcare professional or as outlined in the manufacturer's information. Additionally, proper disposal of used needles and syringes is important to prevent the spread of diseases such as HIV.
